미국 - 영어 - NLM (National Library of Medicine)

padagis us llc - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i) - neomycin 3.5 mg in 1 g - neo-polycin® ophthalmic ointment is indicated for the topical treatment of superficial infections of the external eye and its adnexa caused by susceptible bacteria. such infections encompass conjunctivitis, keratitis, and keratoconjunctivitis, blepharitis and blepharoconjunctivitis. neo-polycin® ophthalmic ointment is contraindicated in individuals who have shown hypersensitivity to any of its components.

미국 - 영어 - NLM (National Library of Medicine)

padagis us llc - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), hydrocortisone acetate (unii: 3x7931po74) (hydrocortisone - unii:wi4x0x7bpj) - neomycin 3.5 mg in 1 g - neo-polycin® hc ophthalmic ointment is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial infection exists. ocular corticosteroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of corticosteroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation, or thermal burns, or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye (see clinical pharmacology: microbiology ). the particular anti-infective drugs in this product are active against the following common bacterial eye

미국 - 영어 - NLM (National Library of Medicine)

padagis us llc - dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql), neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - dexamethasone 1 mg in 1 g - for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists. ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns; or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye. the particular anti-infective drug in this product is active against the following common bacterial eye pathogens: staphylococcus aureus, escherichia coli, haemophilus influenzae, klebsiella/enterobacter

미국 - 영어 - NLM (National Library of Medicine)

padagis us llc - activated charcoal (unii: 2p3vwu3h10) (activated charcoal - unii:2p3vwu3h10) - activated charcoal 25 g in 25 g - poison adsorbent for emergency use to adsorb swallowed poisons

미국 - 영어 - NLM (National Library of Medicine)

padagis us llc - ciclopirox (unii: 19w019zdrj) (ciclopirox - unii:19w019zdrj) - ciclopirox 7.7 mg in 1 g - superficial dermatophyte infections ciclopirox gel, 0.77% is indicated for the topical treatment of interdigital tinea pedis and tinea corporis due to trichophyton rubrum, trichophyton mentagrophytes, or epidermophyton floccosum . seborrheic dermatitis ciclopirox gel, 0.77% is indicated for the topical treatment of seborrheic dermatitis of the scalp. ciclopirox gel, 0.77% is contraindicated in individuals who have shown hypersensitivity to any of its components.

미국 - 영어 - NLM (National Library of Medicine)

padagis us llc - activated charcoal (unii: 2p3vwu3h10) (activated charcoal - unii:2p3vwu3h10) - activated charcoal 208 mg in 1 ml - actidose® with sorbitol and actidose®-aqua should be used in a supervised medical facility or under the direction of a physician or poison control center. actidose® with sorbitol and actidose®-aqua are indicated in the management of many types of poisoning emergencies when a toxin has been ingested or when indicated for a limited number of systemic poisonings resulting from parenteral overdosage or when the toxin has been totally absorbed. if physiologic conditions are optimal, activated charcoal most effectively adsorbs toxins with a molecular weight of 100 - 1,000 daltons (amu’s).1 activated charcoal may not be as effective in adsorbing low molecular weight substances such as aliphatic alcohols (methanol, isopropanol, ethanol, etc.) metals (iron, lead, mercury, etc.) and elements such as lithium.2 . two animal studies have demonstrated that very toxic and low molecular weight cyanide compounds are adsorbed by activated charcoal.21,22 the use of activated charcoal in toxic emergencies involving these subst

미국 - 영어 - NLM (National Library of Medicine)

padagis us llc - podophyllum resin (unii: 16902yvy2b) (podophyllum resin - unii:16902yvy2b) - podophyllum resin 1 mg in 4 ml - podocon-25® (25% podophyllin in benzoin tincture) is indicated for the removal of soft genital (venereal) warts (condylomata acuminata)(4) . podocon-25® is contraindicated in diabetics, patients using steroids or with poor blood circulation. podocon-25® should not be used on bleeding warts, moles, birthmarks or unusual warts with hair growing from them. it is recommended that podocon- 25® not be used during pregnancy (see pregnancy warning below).

미국 - 영어 - NLM (National Library of Medicine)

padagis us llc - methazolamide (unii: w733b0s9sd) (methazolamide - unii:w733b0s9sd) - methazolamide 25 mg - methazolamide tablets usp is indicated in the treatment of ocular conditions where lowering intraocular pressure is likely to be of therapeutic benefit, such as chronic open-angle glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where lowering the intraocular pressure is desired before surgery. methazolamide therapy is contraindicated in situations in which sodium and/or potassium serum levels are depressed, in cases of marked kidney or liver disease or dysfunction, in adrenal gland failure, and in hyperchloremic acidosis. in patients with cirrhosis, use may precipitate the development of hepatic encephalopathy. long-term administration of methazolamide is contraindicated in patients with angle-closure glaucoma, since organic closure of the angle may occur in spite of lowered intraocular pressure.

미국 - 영어 - NLM (National Library of Medicine)

padagis us llc - erythromycin (unii: 63937kv33d) (erythromycin - unii:63937kv33d) - erythromycin 5 mg in 1 g - for the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by organisms susceptible to erythromycin. for prophylaxis of ophthalmia neonatorum due to n. gonorrhoeae or c. trachomatis . the effectiveness of erythromycin in the prevention of ophthalmia caused by penicillinase-producing n. gonorrheae is not established. for infants born to mothers with clinically apparent gonorrhea, intravenous or intramuscular injections of aqueous crystalline penicillin g should be given; a single dose of 50,000 units for term infants or 20,000 units for infants of low birth weight. topical prophylaxis alone is inadequate for these infants. this drug is contraindicated in patients with a history of hypersensitivity to erythromycin.

미국 - 영어 - NLM (National Library of Medicine)

padagis us llc - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5) - sulfacetamide sodium 100 mg in 1 g - for the treatment of conjunctivitis and other superficial ocular infections due to susceptible microorganisms: escherichia coli, staphylococcus aureus, staphylococcus pneumonia, streptococcus (viridans group), haemophilus influenzae, klebsiella species, and enterobacter species . topically applied sulfonamides do not provide adequate coverage against neisseria species, serratia marcescens and pseudomonas aeroginosa . a significant percentage of staphylococcal isolates are completely resistant to sulfa drugs. hypersensitivity to sulfonamides or to any ingredient of the preparation.